HBC(603077)
Search documents
讯息:和邦生物:预计2025年度净利润将出现亏损
Zheng Quan Shi Bao Wang· 2026-01-11 08:28
人民财讯1月11日电,和邦生物(603077)1月11日公告,经财务部门初步测算,预计2025年度归属于上 市公司股东的净利润将出现亏损,主要系公司预计需计提资产减值准备导致。 【资料图】 关键词: 财经频道 财经资讯 ...
和邦生物:预计2025年度净利润将出现亏损
Xin Lang Cai Jing· 2026-01-11 08:05
和邦生物(603077)1月11日公告,经财务部门初步测算,预计2025年度归属于上市公司股东的净利润将 出现亏损,主要系公司预计需计提资产减值准备导致。 ...
和邦生物:预计2025年度归属于上市公司股东的净利润将出现亏损
智通财经网· 2026-01-11 07:55
智通财经APP讯,和邦生物(603077.SH)发布公告,经公司财务部门初步测算,预计2025年度归属于上 市公司股东的净利润将出现亏损,主要系公司预计需计提资产减值准备导致。 ...
草甘膦概念下跌0.44%,6股主力资金净流出超千万元
Zheng Quan Shi Bao Wang· 2026-01-09 08:27
Group 1 - The glyphosate concept sector declined by 0.44%, ranking among the top declines in the concept sector, with major declines seen in companies like Xin'an Chemical, Lier Chemical, and Jiangshan Chemical [1] - Among the companies in the glyphosate sector, eight stocks saw price increases, with Jiangtian Chemical, Taihe Co., and Nuofengxin leading the gains at 0.58%, 0.52%, and 0.46% respectively [1] - The main capital outflow from the glyphosate sector today was 146 million yuan, with 14 stocks experiencing net outflows, and six stocks seeing outflows exceeding 10 million yuan [1] Group 2 - Xin'an Chemical had the highest net capital outflow of 51.38 million yuan, followed by Nuofengxin, Xingfa Group, and Runfeng Co. with outflows of 19.73 million yuan, 14.59 million yuan, and 12.70 million yuan respectively [1] - The stocks with the highest net capital inflow included Yangnong Chemical and Ando Mai A, with inflows of 0.67 million yuan and 0.06 million yuan respectively [2] - The trading volume for Xin'an Chemical was 3.74%, while Lier Chemical had a turnover rate of 4.12% [1][2]
稀土永磁概念下跌0.94% 11股主力资金净流出超亿元
Zheng Quan Shi Bao Wang· 2026-01-08 08:53
Group 1 - The rare earth permanent magnet sector experienced a decline of 0.94%, ranking among the top losers in the concept sector, with companies like Zhongmin Resources, Gree, and Huicheng Environmental Protection showing significant declines [1] - Among the 50 stocks in the rare earth permanent magnet sector, 19 stocks saw price increases, with Yujing Co., Zhangguang Co., and Ruichen Environmental Protection leading the gains at 9.73%, 2.35%, and 1.86% respectively [1] - The sector faced a net outflow of 4.875 billion yuan from major funds, with North Rare Earth seeing the highest outflow of 1.391 billion yuan, followed by Gree, China Aluminum, and Zhongmin Resources [2][3] Group 2 - The top gainers in the market today included the domestic aircraft carrier sector, which rose by 4.70%, and military information technology, which increased by 4.20%, while the rare earth permanent magnet sector was among the top decliners [2] - The main stocks experiencing significant fund outflows included North Rare Earth (-3.54%), Gree (-5.89%), and China Aluminum (-2.85%), indicating a trend of selling pressure in the rare earth sector [3][4] - Conversely, stocks with notable fund inflows included Lingyi Technology, Youyan New Materials, and Hebang Bio, with inflows of 261.62 million yuan, 18.6866 million yuan, and 18.3170 million yuan respectively [5]
东北固收转债分析:2026年1月十大转债-2026年1月
NORTHEAST SECURITIES· 2026-01-05 01:13
1. Report Industry Investment Rating No relevant content provided. 2. Report's Core View The report presents the top ten convertible bonds in January 2026, including their credit ratings, closing prices at the end of December, conversion premium rates, and the trailing twelve - month price - to - earnings ratios (PE - TTM) of their underlying stocks. It also details the business profiles, financial performance, and key highlights of the companies corresponding to these convertible bonds [2][4][6]. 3. Summary by Company 3.1 Zhongte Convertible Bond - **Company Overview**: A globally leading specialized special - steel material manufacturer with an annual production capacity of about 20 million tons of special - steel materials. It has multiple production and raw - material bases, forming a coastal and riverside industrial chain layout [11]. - **Financial Performance**: In 2024, its operating income was 109.203 billion yuan (YoY - 4.22%), net profit attributable to the parent company was 5.126 billion yuan (YoY - 10.41%). In the first three quarters of 2025, operating income was 81.206 billion yuan (YoY - 2.75%), and net profit attributable to the parent company was 4.33 billion yuan (YoY + 12.88%) [11]. - **Company Highlights**: It is one of the world's most comprehensive special - steel enterprises in terms of variety and specification. It has a complete industrial chain, leading cost - control ability, and is seeking external expansion opportunities [12]. 3.2 Shanlu Convertible Bond - **Company Overview**: Focuses on road and bridge engineering construction and maintenance, and is expanding into other fields. It has a complete business and management system [29]. - **Financial Performance**: In 2024, its operating income was 71.348 billion yuan (YoY - 2.3%), net profit attributable to the parent company was 2.322 billion yuan (YoY + 1.47%). In the first three quarters of 2025, operating income was 41.354 billion yuan (YoY - 3.11%), and net profit attributable to the parent company was 1.41 billion yuan (YoY - 3.27%) [29]. - **Company Highlights**: It has the concept of China - specific valuation, potential for improvement in balance sheet and orders, benefits from regional infrastructure plans, and is exploring overseas markets [30]. 3.3 Hebang Convertible Bond - **Company Overview**: Has advantages in resource supply and has completed a basic layout in the chemical, agricultural, and photovoltaic fields, with four major business segments [44]. - **Financial Performance**: In 2024, its operating income was 8.547 billion yuan (YoY - 3.13%), net profit attributable to the parent company was 31 million yuan (YoY - 97.55%). In the first three quarters of 2025, operating income was 5.927 billion yuan (YoY - 13.02%), and net profit attributable to the parent company was 93 million yuan (YoY - 57.93%) [44]. - **Company Highlights**: Its phosphate mines and salt mines contribute profits, and its liquid methionine production is a major profit - contributor [45]. 3.4 Huayuan Convertible Bond - **Company Overview**: Focuses on building a complete vitamin D3 upstream - downstream industrial chain, with products in the vitamin and chemical - preparation fields [56]. - **Financial Performance**: In 2024, its operating income was 1.243 billion yuan (YoY + 13.58%), net profit attributable to the parent company was 309 million yuan (YoY + 60.76%). In the first three quarters of 2025, operating income was 936 million yuan (YoY - 0.2%), and net profit attributable to the parent company was 234 million yuan (YoY - 3.07%) [56]. - **Company Highlights**: It has leading products in the market, is expanding its product matrix, and has a strong layout in the pharmaceutical manufacturing field [57]. 3.5 Xingye Convertible Bond - **Company Overview**: One of the first joint - stock commercial banks in China, evolving into a modern financial service group with multiple financial licenses [70]. - **Financial Performance**: In 2024, its operating income was 212.226 billion yuan (YoY + 0.66%), net profit attributable to the parent company was 77.205 billion yuan (YoY + 0.12%). In the first three quarters of 2025, operating income was 161.234 billion yuan (YoY - 1.82%), and net profit attributable to the parent company was 63.083 billion yuan (YoY + 0.12%) [70]. - **Company Highlights**: It has stable asset quality and scale growth, with a large number of customers [71]. 3.6 Aima Convertible Bond - **Company Overview**: The leading enterprise in the electric two - wheeled vehicle industry, producing and selling electric bicycles, scooters, and motorcycles [80]. - **Financial Performance**: In 2024, its operating income was 21.606 billion yuan (YoY + 2.71%), net profit attributable to the parent company was 1.988 billion yuan (YoY + 5.68%). In the first three quarters of 2025, operating income was 21.093 billion yuan (YoY + 20.78%), and net profit attributable to the parent company was 1.907 billion yuan (YoY + 22.78%) [80]. - **Company Highlights**: It may benefit from government subsidies, new national standards, and has potential for improving gross margins [81]. 3.7 Chongyin Convertible Bond - **Company Overview**: The earliest local joint - stock commercial bank in the upper reaches of the Yangtze River and Southwest China, listed on the Hong Kong Stock Exchange and included in the "Leading Sheep" plan [90]. - **Financial Performance**: In 2024, its operating income was 13.679 billion yuan (YoY + 3.54%), net profit attributable to the parent company was 5.117 billion yuan (YoY + 3.8%). In the first three quarters of 2025, operating income was 11.74 billion yuan (YoY + 10.4%), and net profit attributable to the parent company was 4.879 billion yuan (YoY + 10.19%) [90]. - **Company Highlights**: It benefits from the regional economic development, has stable asset - scale growth, and actively adjusts its business strategies [91][94]. 3.8 Tianye Convertible Bond - **Company Overview**: The first industrial enterprise of the Xinjiang Production and Construction Corps, a leading enterprise in the chlor - alkali chemical industry with an integrated circular economy industrial chain [103]. - **Financial Performance**: In 2024, its operating income was 11.156 billion yuan (YoY - 2.7%), net profit attributable to the parent company was 68 million yuan (YoY + 108.83%). In the first three quarters of 2025, operating income was 7.97 billion yuan (YoY + 2.2%), and net profit attributable to the parent company was 7 million yuan (YoY - 28.79%) [103]. - **Company Highlights**: It has cost - advantage in caustic soda production and plans to increase dividend frequency and has coal - mine projects in progress [106]. 3.9 Aorui Convertible Bond - **Company Overview**: A company focusing on the R & D, production, and sales of complex APIs and preparations, leading in several technical fields [119]. - **Financial Performance**: In 2024, its operating income was 1.476 billion yuan (YoY + 16.89%), net profit attributable to the parent company was 355 million yuan (YoY + 22.59%). In the first three quarters of 2025, operating income was 1.237 billion yuan (YoY + 13.67%), and net profit attributable to the parent company was 354 million yuan (YoY + 24.58%) [119]. - **Company Highlights**: It is optimizing its distribution network, expanding its overseas market for preparations, and has high - quality customer resources [120]. 3.10 Yushui Convertible Bond - **Company Overview**: The largest water supply and drainage integrated enterprise in Chongqing, with a monopoly position in the local market [133]. - **Financial Performance**: In 2024, its operating income was 6.999 billion yuan (YoY - 3.52%), net profit attributable to the parent company was 785 million yuan (YoY - 27.88%). In the first three quarters of 2025, operating income was 5.568 billion yuan (YoY + 7.21%), and net profit attributable to the parent company was 779 million yuan (YoY + 7.1%) [133]. - **Company Highlights**: It has a high market share, is expanding its business regionally, and has achieved cost control through intelligent applications [134].
和邦生物为子公司提供1.3亿元担保,累计担保72.79亿元
Bei Ke Cai Jing· 2026-01-04 10:14
新京报贝壳财经讯 1月4日,和邦生物发布公告称,2025年12月30日,公司与工行乐山五通桥支行签订 《最高额保证合同》,为全资子公司和邦农科提供1.30亿元连带责任保证,期限至2028年12月31日,无 反担保。截至2025年12月31日,公司及子公司对外担保总额72.79亿元,占最近一期经审计净资产的 39.08%,无逾期担保。 ...
和邦生物(603077) - 和邦生物关于可转债转股结果暨股份变动公告
2026-01-04 08:31
证券代码:603077 证券简称:和邦生物 公告编号:2026-002 债券代码:113691 债券简称:和邦转债 四川和邦生物科技股份有限公司 关于可转债转股结果暨股份变动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: ● 累计转股情况:截至 2025 年 12 月 31 日,四川和邦生物科技股份有限公 司(以下简称"公司"、"本公司")可转债"和邦转债"累计转股金额为 558,000 元,累计因转股形成的股份数量 279,000 股,占可转债转股前公司已发行股份总 额的 0.0032%。 ● 未转股可转债情况:截至 2025 年 12 月 31 日,尚未转股的"和邦转债" 金额为 4,599,442,000 元,占可转债发行总量的 99.9879%。 ● 本季度转股情况:2025 年 10 月 1 日至 2025 年 12 月 31 日,"和邦转债" 转股金额为 276,000 元,因转股形成的股份数量为 138,000 股。 一、可转债发行上市概况 经中国证券监督管理委员会证监许可[2024]123 ...
和邦生物(603077) - 和邦生物关于提供担保的进展公告
2026-01-04 08:30
| 证券代码:603077 | 证券简称:和邦生物 | 公告编号:2026-001 | | --- | --- | --- | | 债券代码:113691 | 债券简称:和邦转债 | | 四川和邦生物科技股份有限公司 关于提供担保的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 担保对象及基本情况 | | 本次担保金额 | 实际为其提供的 担保余额(不含本 次担保金额) | 是否在前期预计 额度内 | 本次担保是否有 反担保 | | --- | --- | --- | --- | --- | | | 13,000.00 万元 | 34,500.00 万元 | 是 | 否 | | 被担保人名称 乐山和邦农业科技 有限公司 | | | | | | 对外担保逾期的累计金额(万元) | 0 | | --- | --- | | 截至本公告日上市公司及其控股 | 727,897.73 | | 子公司对外担保总额(万元) | | | 对外担保总额占上市公司最近一 | 39.08 | | 期经审计净资产的比例(%) ...
和邦生物:为子公司提供1.3亿元担保,累计担保72.79亿元
Xin Lang Cai Jing· 2026-01-04 08:15
和邦生物公告称,2025年12月30日,公司与工行乐山五通桥支行签订《最高额保证合同》,为全资子公 司和邦农科提供1.30亿元连带责任保证,期限至2028年12月31日,无反担保。截至2025年12月31日,公 司及子公司对外担保总额72.79亿元,占最近一期经审计净资产的39.08%,无逾期担保。和邦农科2025 年1-9月营收24.89亿元,净利润1.26亿元。 ...